Location History:
- Ibaraki, JP (2001 - 2006)
- Kashima, JP (2008)
Company Filing History:
4 out of 677 
1 out of 832,843 Years Active: 2001-2008
Title: Akio Kayano: Pioneering Innovations in Pharmaceutical Chemistry
Introduction
Akio Kayano, an accomplished inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a portfolio of five patents, his work focuses on innovative methods for producing complex chemical compounds, specifically cyclic benzamidine derivatives and carbapenem compounds.
Latest Patents
Among his latest innovations, Kayano has developed several methods for producing cyclic benzamidine derivatives. These methods include the reaction of specific novel compounds with ammonia or imide to create fluorinated cyclic benzamidine derivatives. Additionally, he has outlined comprehensive processes for producing morpholine-substituted phenacyl derivatives by reacting with morpholine and other reagents. His work also covers recrystallization techniques for cyclic benzamidine derivatives, ensuring high purity of the final products. Furthermore, he has contributed to the development of stable, chemically pure carbapenem hydrochloride trihydrate crystals, which serve as effective antimicrobial agents, along with a powdery charged preparation for injection.
Career Highlights
Kayano's career includes significant engagement with Eisai Company, Limited, where he utilized his expertise to advance drug development processes. His innovative approaches to chemical synthesis have positioned him as a notable figure in pharmaceutical research.
Collaborations
Throughout his career, Akio Kayano has collaborated with distinguished professionals in his field, including Hiroyuki Chiba and Masahiko Tsujii. These partnerships have likely facilitated the advancement of his notable inventions and broadened the impact of his research.
Conclusion
In summary, Akio Kayano stands out as a prolific inventor whose contributions significantly impact pharmaceutical chemistry. His innovative methods and collaborative efforts continue to foster advancements in the field, enhancing the quality and efficacy of therapeutic agents.